207 results
Page 4 of 11
8-K
EX-99
cbnrl5az4efj705
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:33pm
8-K
EX-4.1
00xterx 9rcx7ui9a
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-10.2
g47 opur3lez6kjjb8
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-99
y8v4qlvh4n shfz
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-10.1
2stf94lnjxcmhekj7
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-99
p7gq12 p66
5 Aug 20
Other Events
12:00am
8-K
EX-99
gwjzj6fcppar 2w
31 Jul 20
Results of Operations and Financial Condition
4:28pm
8-K
EX-99
yly8oy8xfqnewj
27 Jul 20
Entry into a Material Definitive Agreement
6:50am
8-K
EX-99
nwdal9puwpv8c2qs0ffp
6 Jul 20
Entry into a Material Definitive Agreement
6:43am
8-K
EX-99
oh4 5dn3g9k
11 Jun 20
Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate
4:39pm
8-K
EX-99
bwdzgswmadtx
8 Jun 20
Regulation FD Disclosure
6:29am
8-K
EX-99
5iul42k3nir
1 Jun 20
Entry into a Material Definitive Agreement
8:45am
8-K/A
EX-99.1
f5vpx09t
30 Apr 20
Emergent Biosolutions Reports Financial Results for First Quarter 2020
9:54pm
8-K
EX-99.1
c9yfk 2ib8
30 Apr 20
Emergent Biosolutions Reports Financial Results for First Quarter 2020
4:34pm
8-K
EX-99
6vi28u 5wryp0x6drbh
24 Apr 20
Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19
12:00am